Skip to main content
Clinical Trials/EUCTR2011-000994-30-AT
EUCTR2011-000994-30-AT
Active, not recruiting
Not Applicable

A randomized, double-blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on metabolic and fertility parameters in PCOS women

Medizinische Universität Graz0 sitesJanuary 24, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic Ovary Syndrome
Sponsor
Medizinische Universität Graz
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2013
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • PCOS women:
  • 1\) Premenopausal women \=18 years
  • 2\) Polycystic ovary syndrome: 2 out of the following criterias are required:
  • a) Oligo\- or anovulation
  • b) Biochemical and/or clinical hyperandrogenism
  • c) Polycystic ovaries
  • 3\) 25(OH)D \<30 ng/ml
  • Healthy women:
  • 1\) Premenopausal women \=18 years
  • 2\) Exclusion of Polycystic ovary syndrome

Exclusion Criteria

  • PCOS women:
  • Hypercalcemia
  • Withdrawn informed consent
  • Hormonal contraception in the last 3 months before entering the study
  • Insulin sensitizing agents in the last 6 months before entering the study
  • Lipid lowering agents and drugs affecting androgens and insulin sensitivity in the last 3 months before entering
  • Vitamin D supplementation in the last 3 months before entering the study
  • Hyperandrogenism caused by other diseases than polycystic ovary syndrome (Cushing disease, adrenogenital
  • Healthy women:
  • diagnosed PCOS or any of the following criteria:

Outcomes

Primary Outcomes

Not specified

Similar Trials